Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
5 Patents
#5 in
#6,098 in Germany
Bionorica Se
Forward Citations = 7
8 inventors:
Bionorica Se
% Expired Patents = 20.0
CIPO Patents = 1
EPO Patents = 12
Trademarks = 10
Forward Citations = 7
Loading Chart...
Loading Chart...
8 inventors (with patents filed for the assignee):
Michael A Popp (4 out of 10 patents)
Guenther Bonn (1 out of 8 patents)
Guenther Stecher (1 out of 1 patent)
4. Robert Mayer (1 out of 1 patent)
5. Martin Dittmer (1 out of 1 patent)
6. Stefan Wiesneth (1 out of 1 patent)
7. Matthias Ferstl (1 patent)
8. Günther Stecher (2 patents)
9. Wolfgang Wuttke (2 patents)
10. Markus Reher (1 patent)
11. Silvia Fersch (0 patent)
12. Moritz Rubner (0 patent)
13. Stefanie Delueg (0 patent)
14. Martin Dittmer (0 patent)
15. Rudolf Bauer (0 patent)
5 patents:
Company Overview
Bionorica SE is a German pharmaceutical company specializing in plant-based medicine. With a focus on natural remedies, Bionorica is dedicated to the research, development, and production of pharmaceutical products derived from plants. Their innovative approach has led to the creation of effective treatments for a variety of ailments, all while maintaining a commitment to sustainability and environmental responsibility.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bionorica Se. Retrieved from https://idiyas.com/company/bionorica-se
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
12 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]